SARS-CoV-2 Immunoglobulin G Rapid Test

BioHermes SARS-CoV-2 IgG Antibody Test (Lateral Flow Assay) is intended for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum，plasma and venous whole blood. This Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. BioHermes SARS-CoV-2 IgG Antibody Test (Lateral Flow Assay) is with the following advantages: -Easy to use, visual reading of results -Instant result in 10 miutes -Various sample type: serum; plasma; whole blood -90.0% sensitivity,100% specificity (compared to PCR confirmed specimen ) The Clinical Value of SARS-CoV-2  IgG detection for COVID-19 are: -Proven diagnostic criteria to assist the COVID-19 diagnostic -Assist the exclusion of non-COVID-19 patients -COVID-19 screening -Epidemiological follow-up